The U.S. Food and Drug Administration has approved the marketing of two extra genital diagnostic testings for the sexually transmitted infections chlamydia and gonorrhea. FDA Clears 2 New STI Testing Devices The Aptima Combo 2 Assay and the Xpert CT/NG can detect the presence of the bacteria Chlamydiatrachomatis and Neisseria gonnorrhoeae through the examination of extragenital specimens. The two devices are the first to...
Post
Transcranial Magnetic Stimulation Improves Working Memory
Researchers from Duke University School of Medicine have found that magnetic brain stimulation can help improve working memory. They studied repetitive transcranial magnetic stimulation (rTMS), showing that it improved memory task performance in all ages of adults. Given that individuals with Alzheimer’s will more than double by 2050, rTMS may be a potential form of...
Post
First PI3K inhibitor approved for metastatic, advanced breast cancer
(HealthDay)—Piqray (alpelisib) tablets were approved for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer in combination with fulvestrant, the U.S. Food and Drug Administration announced Friday. The tablets were approved for use in men and postmenopausal women whose disease progressed after treatment with an endocrine-based regimen. The drug was also approved in combination with a companion diagnostic test, the...
Post
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
By ELIE DOLGINMAY 29, 2019 The first two rounds of treatment went off without a hitch. But last November, after receiving a third dose of potent immunotherapy for his skin cancer, Rich Lenihan started to feel tired and weak. He was urinating constantly, and no amount of water could abate his thirst. A blood test...
Post
More isn’t better when it comes to evaluating chest pain
Study shows that extensive testing doesn’t help predict major cardiac events UNIVERSITY OF CALIFORNIA – DAVIS HEALTH Most patients seen in a hospital emergency department for chest pain did not experience major cardiac events within six months following discharge, new research from UC Davis Health and Oregon Health Sciences University cardiologists shows. Also, the few study participants who...
Post
To treat an eating disorder, we need to know what emotion fuels it
by Julianna Photopoulos, From Horizon Magazine, Horizon: The EU Research & Innovation Magazine Pinpointing how different emotional states and neural pathways influence our eating behaviours could pave the way for better ways to tackle eating disorders and obesity. Eating disorders such as anorexia and bulimia can have life-threatening consequences. They affect around 20 million people in the European Union, with an estimated cost...
Post
Clinical trial assesses telephone-based care program for at-risk homebound elderly
by Deborah Mann Lake, University of Texas Health Science Center at Houston Something as simple as a phone call could be a way to alert health care providers and caregivers that an elderly person suffering from dementia may be spiraling down to dangerous self-neglect, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). To test their premise, Sabrina Pickens, Ph.D., MSN,...
Post
Cannabis use among older adults rising rapidly
Study is first state-wide investigation of cannabis use among older Americans and the outcomes they experience UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS AURORA, Colo. (May 30, 2019) – Cannabis use among older adults is growing faster than any other age group but many report barriers to getting medical marijuana, a lack of communication with their doctors and a lingering stigma attached...
Post
Nerivio Migra Wins FDA De Novo Clearance for Acute Treatment of Migraines
Theranica, a company based in Israel, won FDA De Novo clearance for its Nerivio Migra smartphone-operated electroceutical device for treating migraine headaches. The device is worn around the upper arm, from where it delivers electronic pulses into the skin to generate a so-called “Conditioned Pain Modulation” response. This helps to mitigate the effects of a migraine in patients with or without aura, and...
Post
Heartburn drugs linked to fatal heart and kidney disease, stomach cancer
Death risk increases the longer such drugs are used WASHINGTON UNIVERSITY IN ST. LOUIS Extended use of popular drugs to treat heartburn, ulcers and acid reflux has been associated with an increased risk of premature death. However, little has been known about the specific causes of death attributed to the drugs. Now, a study by researchers at Washington University School of...